Mainstream

Gsk boss 'highly confident' sales will top £40bn by 2031 as firm cashes in on cancer and hiv drugs

GSK boss ‘highly confident’ sales will top £40bn by 2031 as firm cashes in on cancer and HIV drugs

GSK boss ‘highly confident’ sales will top £40bn by 2031 as firm cashes in on cancer and HIV drugs

GSK, led by boss Emma Walmsley (pictured), saw revenues rise 5% to £15.5bn in the first half of the year and profits were up 41% to £4.2bn.Read More

You might also be interested in reading Tether Expects to Invest Over $1B in Deals in the Next Year: Bloomberg.

July 30, 2025
In Mainstream